Accurdx
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $14M
Investors
- 3
About Accurdx
, trading as Accurdx, operates as an in vitro diagnostic instrument and supporting reagent manufacturer, focusing on medical diagnostic reagents, and diagnostic instruments. Some affiliations have been established in Beijing, Shanghai, Suzhou, and Hangzhou. Accurdx has obtained 45 production licenses, 10 full-automatic analyzer registrations, 35 reagent registrations, and 83 patents for inventions and other items. The products manufactured by the company can be categorized into four categories which are coagulation tests, specific protein tests, genital tract secretion tests, and immune tests. Products within include coagulation analyzers, coagulation reagents, blood sedimentation analyzers, genital secretion analyzers, and dry fluorescence and immune analyzers. The technologies and products can provide clinical laboratory automation solutions for bleeding and bleeding control, cardiovascular disease, and colon cancer screening. The company generates revenue primarily through the sale of in vitro diagnostic instruments, supporting reagents, and integrated diagnostic systems to clinical laboratories and medical institutions. Additional revenue is derived from the commercialization of automated laboratory solutions and the provision of related technical and support services. Its vertically integrated structure enables coordinated sales of instruments, reagents, and system-level solutions.
Who invested in Accurdx
3 investors across 2 rounds
See all investors in Accurdx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Accurdx
Who invested in Accurdx?
Accurdx has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Accurdx raised?
Accurdx has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Accurdx last raise money?
Accurdx's most recent round on record is a Series A, in Sep 2023.
What does Accurdx do?
, trading as Accurdx, operates as an in vitro diagnostic instrument and supporting reagent manufacturer, focusing on medical diagnostic reagents, and diagnostic instruments.
Where is Accurdx headquartered?
Accurdx is headquartered in Jinan, China.
Which VCs invest in companies like Accurdx?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Accurdx's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Accurdx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.